• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·PGHH.NS
Share

Procter & Gamble Hygiene and Health Care Limited Stocks

₹ 7119Last Updated 14.10.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

₹ 2.33B

₹ 7119
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1964 and headquartered in Mumbai, India, Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of Procter & Gamble Overseas India BV. The company specializes in the manufacturing and worldwide distribution of branded packaged fast-moving consumer goods, with a particular emphasis on feminine care and healthcare segments. Its product range within healthcare includes various topical solutions like ointments and creams, as well as cough suppressants and medicinal tablets. For hygiene, it offers feminine hygiene essentials, such as pads, alongside other skin-focused hygiene items. The comprehensive portfolio extends further to cover baby care products, including nappies, pants, and wipes, along with diverse lines for laundry, hair care, home care, and oral care. These offerings are marketed under prominent brands such as Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice. The company's goods are made available to consumers through an extensive network of retail channels, encompassing mass merchandisers, grocery stores, membership clubs, pharmacies, department stores, and various high-frequency retail outlets.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of PGHH.NS is 13485 and suggests 93.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.10.2026 12:53

Anthropic's revenue surge will help its IPO, but is unlikely to save the entire AI sector, experts say

15.10.2026 12:37

"They Started Catching Up Late, but Quickly": Movchan's Group Guide to Investing in Kazakhstan

15.10.2026 12:21

Freedom recommended buying shares in Marriott, Hilton, and other hotel chains. What's the opportunity here?

15.10.2026 11:07

The world's leading chipmaker posted record profits for the sixth consecutive time

15.10.2026 10:26

Morning Highlights: Global Stocks Fall; Anthropic Reports Revenue Growth Ahead of Its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026